Why Experimental Evidence Needs Careful Interpretation
An association at a genetic locus identifies a statistical relationship, not by itself the molecular process that produced it. Functional experiments can help test whether alleles or genomic regions affect molecular outcomes. Three commonly used approaches are allele-specific expression (ASE), reporter assays, and CRISPR perturbations. Their evidence is informative in different ways: ASE measures allelic differences in a shared cellular environment, reporter assays compare sequence constructs, and CRISPR experiments alter DNA or gene activity in cells.
A result is strongest when the experimental contrast is clear, the controls address plausible technical alternatives, and the measured outcome is interpreted in its biological context. Even then, an effect in one assay or cell type does not automatically establish the mechanism of a trait association in people.
Allele-Specific Expression
The key advantage of ASE is that both alleles are measured within the same individual and cellular sample. They therefore share many trans-acting influences, such as the cell's environment and concentrations of transcription factors. A difference between the alleles is consistent with a local, or cis, influence. It does not identify which nearby sequence change caused that difference.
An informative analysis needs a heterozygous transcribed marker that distinguishes the two chromosome copies, adequate RNA coverage, and reliable assignment of reads to alleles. The marker may be the candidate variant if it is transcribed, or a phased marker linked to it. Phasing establishes which alleles at different sites occur on the same chromosome. Allele labels and genomic orientation should be checked consistently; a read-count imbalance cannot be interpreted as an effect of the candidate allele if the reads cannot be linked to it.
A simple model illustrates the equal-expression reference point. Suppose \(X\) of \(N\) independent, informative RNA molecules carry one allele. Under equal allelic expression and unbiased read assignment, \(X\) has a binomial distribution with success probability one half.
The variance follows from the binomial variance \(Np(1-p)\), substituting \(p=0.5\). Thus, even under equal expression, observed counts will usually not be exactly equal. This model is a useful reference, not a guarantee that a naive binomial test is calibrated: reads can be correlated because of amplification, and technical bias or biological variation can make the simple model too optimistic.
Worked Example: Correcting an Allelic Ratio With a DNA Control
Hypothetical data. In a heterozygous sample, RNA sequencing yields 72 reads assigned to the alternate allele and 48 to the reference allele at a transcribed, phased marker. Sequencing genomic DNA from the same sample yields 50 reads for each allele. Assume, for this descriptive calculation, that the DNA counts provide a useful estimate of allele-specific measurement bias and that the marker is correctly phased to the candidate allele.
The raw RNA ratio of alternate to reference reads is \(72/48=1.50\). The DNA ratio is \(50/50=1.00\). A DNA-normalized allelic ratio is therefore:
The alternate-linked allele has 1.50 times the measured RNA abundance of the reference-linked allele after this simple normalization. On the log base 2 scale, the contrast is \(\log_2(1.50)\approx 0.585\). This is a dimensionless allelic effect estimate, not a 0.585-unit change in gene expression. The result describes the sample and marker; without biological replication and a model for count variability, it is not by itself evidence of a reproducible population-level effect.
Reporter Assays: Comparing Allele Constructs
A reporter assay places a candidate sequence, such as a promoter or enhancer fragment, next to a measurable reporter gene. In a common design, otherwise matched constructs carry either the reference or alternate allele. Reporter output then estimates how the tested sequence affects expression in the chosen assay system.
The comparison is interpretable only if the constructs differ as intended and the assay controls work. Useful controls include a promoterless or minimal-promoter construct to characterize background, a positive control when available, and a normalization reporter to account for differences in transfection or sample handling. Replicate independent transfections are more informative than repeated instrument readings from the same transfection. The tested sequence, orientation, construct backbone, cell type, and treatment conditions all define what the result means.
Worked Example: Comparing Reference and Alternate Reporter Constructs
Hypothetical data. In four independent transfections per construct, normalized reporter outputs are 100, 105, 95, and 100 units for the reference construct, and 130, 125, 135, and 130 units for the alternate construct. A promoterless control has a mean output of 5 units, and a normalization reporter is used to adjust for transfection efficiency. Assume the constructs are sequence-verified and differ only at the tested allele.
The reference mean is \((100+105+95+100)/4=400/4=100\) reporter units. The alternate mean is \((130+125+135+130)/4=520/4=130\) reporter units. The mean difference is \(130-100=30\) reporter units, and the alternate-to-reference fold difference is \(130/100=1.30\), or 30% higher normalized output.
In this construct and cell context, the alternate allele is associated with higher reporter output. The low promoterless output is consistent with a functioning assay background control, and normalization addresses a source of variation in transfection. These facts do not establish that the allele increases expression of its endogenous target gene in human tissue: an isolated construct may lack native chromatin, long-range interactions, or other sequence context. The four transfections, not the number of instrument readings within them, are the independent experimental units for assessing reproducibility.
CRISPR Perturbations: What Was Actually Changed?
CRISPR-based experiments can perturb a gene or a regulatory region. Deleting or repressing an enhancer tests whether that element contributes to an outcome in the tested cells. It does not, by itself, show that a particular candidate nucleotide within the element is functional. A variant-specific test instead changes the candidate base while leaving surrounding sequence as intact as possible; precise editing can therefore provide more direct evidence about that nucleotide.
Interpretation depends on the intervention and its controls. Non-targeting guides help measure outcomes unrelated to targeting, while independent guides can reveal guide-specific effects. Editing should be verified, and the measured outcome should be compared across suitable biological replicates. Potential off-target effects, cell viability changes, and unintended effects of a deletion or repression method must also be considered. A rescue experiment—restoring the targeted sequence or downstream function—can strengthen a causal interpretation, but does not erase limitations of the system.
Worked Example: Interpreting a Regulatory-Element Deletion
Hypothetical data. Researchers delete a candidate enhancer in a cultured cell type and measure normalized expression of a nearby gene. Four independent cultures targeted with a guide to the enhancer have expression values of 7.8, 8.1, 7.9, and 8.2 units. Four cultures receiving a non-targeting guide have values of 9.8, 10.1, 10.0, and 10.1 units. Assume the deletion is verified, the cultures were processed in parallel, and the outcome has been normalized using a prespecified procedure.
The deletion-group mean is \((7.8+8.1+7.9+8.2)/4=32.0/4=8.0\) expression units. The non-targeting-control mean is \((9.8+10.1+10.0+10.1)/4=40.0/4=10.0\) units. The difference is \(8.0-10.0=-2.0\) units. Relative to the control mean, this is \((-2.0/10.0)\times100=-20\%\).
Under these conditions, the deletion is associated with 2.0 fewer normalized expression units, or 20% lower mean expression, than the non-targeting control. This supports a role for the targeted region in maintaining expression in this cell system, subject to guide-specific and other experimental limitations. It does not isolate the candidate nucleotide: deleting an entire element removes many bases and may disrupt local structure. Nor does the result alone establish the effect in another tissue or on a complex trait.
Effect Direction, Controls, and Scope
Effect direction must always be stated relative to the outcome measured. For ASE, identify which phased allele has higher RNA abundance. For a reporter assay, specify which construct has higher reporter output. For a CRISPR experiment, describe the outcome after the stated perturbation relative to its control. None of these directions automatically says whether the allele increases disease risk or changes a clinical phenotype. That further interpretation requires a justified link between the molecular outcome and the trait, including consistent allele orientation.
| Evidence type | Direct contrast | Important interpretive limit |
|---|---|---|
| Allele-specific expression | RNA contribution of two alleles within a heterozygote | Imbalance may reflect a linked variant, read-assignment bias, or sample-specific effects |
| Reporter assay | Output from alternative sequence constructs | Construct activity may not represent the endogenous locus or native chromatin context |
| CRISPR perturbation | Outcome after targeted edit, deletion, or repression versus controls | A region-level perturbation may not identify the causal base or generalize across cell contexts |
The three approaches answer related but distinct questions. ASE asks whether the two chromosome copies differ in RNA output in a sample. A reporter assay asks whether a tested sequence changes reporter output in a particular experimental system. A CRISPR experiment asks what happens when a specified DNA region, base, or gene is perturbed in a particular cellular context. Agreement across methods can make a functional interpretation more plausible, but the methods should not be treated as interchangeable measurements of the same effect.
Common Mistakes and a Practical Reading Sequence
- Calling a raw read imbalance proof of ASE. Unequal counts can result from mapping or amplification bias. Check allele assignment, genomic DNA or other bias controls, and biological replication.
- Assigning an observed effect to the wrong allele. If the marker is not phased to the candidate variant, the read-count direction does not establish whether the candidate alternate allele has higher expression.
- Treating reporter output as endogenous gene expression. A reporter measures construct activity in its assay conditions; it may omit native chromatin and long-range regulation.
- Claiming a specific variant from a whole-element deletion. The deletion tests the region as perturbed, not each nucleotide within it. A variant-specific edit is needed to isolate the candidate base more directly.
- Translating molecular direction directly into trait direction. Higher expression or reporter activity is not automatically higher disease risk. The molecular-to-trait relationship must be established separately.
A disciplined reading starts by naming the intervention or allelic comparison, the measured outcome, and the control. Next, check whether the contrast isolates the intended allele or region and whether technical and biological replication support it. Finally, state the direction and size in the assay's units, then limit the conclusion to the tested sequence, cells, and conditions. This approach preserves what the experiment shows without turning functional support into a stronger causal claim than the design warrants.
Check Your Understanding
Answer each question by identifying both the evidence and its main interpretive limit.
- Why can comparing two alleles within the same heterozygous sample help control for trans-acting influences?
- A transcribed marker shows more reads for one allele. Name two reasons, other than true allelic expression imbalance, that could produce this pattern.
- A reporter construct with the alternate allele has higher output than the reference construct. What does this establish about the tested system, and what does it not establish about endogenous expression?
- Why does deleting an enhancer not, by itself, prove that a particular candidate nucleotide within it is functional?
- After CRISPR perturbation, a gene's expression is lower than in a non-targeting control. State the effect direction carefully and give one reason it may not generalize to another tissue.